Prolytix, formerly Haematologic Technologies, Inc. (HTI), is a leading provider of analytical and bioanalytical services supporting the research, development, and commercialization of large-molecule biotherapeutics and high-quality reagents for coagulation research. With more than 35 years of experience, Prolytix specializes in solving the most complex large-molecule challenges.